Company / R&D per Share
ENvue Medical, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$23.99
FY2025
5-year range
$0.01 / $23.99
FY2021-FY2025
Trend
+2312.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +2312% YoY in FY2025, a notable deviation from the 9-year average annual change of +556%.
Based on SEC 10-K filings.
23.99 in FY2025 with a 5-year CAGR of +187.4%.
Improved from $0.17 to $23.99 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +385.7%
- 5-Year CAGR
- +187.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 2312.1% year-over-year.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.99 | +2312.1% |
| FY2024 | $0.99 | +476.7% |
| FY2023 | $0.17 | -17.6% |
| FY2022 | $0.21 | +2329.6% |
| FY2021 | $0.01 | -93.0% |
| FY2020 | $0.12 | -24.3% |
| FY2019 | $0.16 | -8.3% |
| FY2018 | $0.18 | -20.6% |
| FY2017 | $0.22 | +45.2% |
| FY2016 | $0.15 | -94.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026